Lehmann Brewer

Greater than six million people global, including one million in the United States, live with Parkinson's disease-a persistent, degenerative, neurological condition that is characterized by symptoms that usually progress from mild tremors to significant physical incapacitation. Best Jobs For Certified Dietitians contains more concerning when to engage in this viewpoint.

Despite modest advances in pharmaceutical and surgical treatments, there is no known cure for Parkinson's. The most readily useful hope for finding one, say experts in the field, is through clinical studies. Therein lies the issue.

Even though almost all (more than 96 percent) of the physicians in the Usa who treat people with Parkinson's disease agree that clinical trials are necessary to find better remedies for the disease, many physicians have never referred a to a clinical trial.

These are on the list of features of the recent study commissioned by Advancing Parkinson's Therapies (APT), a collaborative effort headed by leading Parkinson's businesses. The survey also found that, among Parkinson's patients, 40 percent cite organizations and 27 percent cite other people with the condition because the most frequent sources of information about clinical trials. Meanwhile, only 11 % of people get information from their doctors.

Currently, less than 1 percent of men and women with Parkinson's are participating in medical research. This is far short of the amount that experts anticipate will be needed for clinical studies within the next two to three years, including studies of therapies to slow or stop disease progression and to improve symptoms such as tremors. This disparity may possibly result in significant delays in the availability of new remedies.

Information Obstacles

Lack of sufficient details about clinical trials was recognized as an obstacle to clinical trial enrollment. Only 1-4 percent of primary care doctors, 21 percent of neurologists and 18 percent of patients interviewed indicated they are somewhat or very satisfied with the quantity of information available about clinical trials for Parkinson's disease. To get additional information, please take a peep at: clinical dietitian job.

"People aren't getting the information they need to make decisions as to whether to